Literature DB >> 25510215

Mapping the disease-specific LupusQoL to the SF-6D.

Rachel Meacock1, Mark Harrison, Kathleen McElhone, Janice Abbott, Sahena Haque, Ian Bruce, Lee-Suan Teh.   

Abstract

PURPOSE: To derive a mapping algorithm to predict SF-6D utility scores from the non-preference-based LupusQoL and test the performance of the developed algorithm on a separate independent validation data set.
METHOD: LupusQoL and SF-6D data were collected from 320 patients with systemic lupus erythematosus (SLE) attending routine rheumatology outpatient appointments at seven centres in the UK. Ordinary least squares (OLS) regression was used to estimate models of increasing complexity in order to predict individuals' SF-6D utility scores from their responses to the LupusQoL questionnaire. Model performance was judged on predictive ability through the size and pattern of prediction errors generated. The performance of the selected model was externally validated on an independent data set containing 113 female SLE patients who had again completed both the LupusQoL and SF-36 questionnaires.
RESULTS: Four of the eight LupusQoL domains (physical health, pain, emotional health, and fatigue) were selected as dependent variables in the final model. Overall model fit was good, with R(2) 0.7219, MAE 0.0557, and RMSE 0.0706 when applied to the estimation data set, and R(2) 0.7431, MAE 0.0528, and RMSE 0.0663 when applied to the validation sample.
CONCLUSION: This study provides a method by which health state utility values can be estimated from patient responses to the non-preference-based LupusQoL, generalisable beyond the data set upon which it was estimated. Despite concerns over the use of OLS to develop mapping algorithms, we find this method to be suitable in this case due to the normality of the SF-6D data.

Entities:  

Mesh:

Year:  2014        PMID: 25510215     DOI: 10.1007/s11136-014-0892-4

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  40 in total

1.  The estimation of a preference-based measure of health from the SF-36.

Authors:  John Brazier; Jennifer Roberts; Mark Deverill
Journal:  J Health Econ       Date:  2002-03       Impact factor: 3.883

Review 2.  OMERACT 6 Economics Working Group report: a proposal for a reference case for economic evaluation in rheumatoid arthritis.

Authors:  Sherine Gabriel; Michael Drummond; Andreas Maetzel; Maarten Boers; Doug Coyle; Vivian Welch; Peter Tugwell
Journal:  J Rheumatol       Date:  2003-04       Impact factor: 4.666

3.  Agreement about identifying patients who change over time: cautionary results in cataract and heart failure patients.

Authors:  David Feeny; Karen Spritzer; Ron D Hays; Honghu Liu; Theodore G Ganiats; Robert M Kaplan; Mari Palta; Dennis G Fryback
Journal:  Med Decis Making       Date:  2011-10-18       Impact factor: 2.583

4.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

5.  Mapping to obtain EQ-5D utility values for use in NICE health technology assessments.

Authors:  Louise Longworth; Donna Rowen
Journal:  Value Health       Date:  2013 Jan-Feb       Impact factor: 5.725

Review 6.  Systemic lupus erythematosus.

Authors:  Sean O'Neill; Ricard Cervera
Journal:  Best Pract Res Clin Rheumatol       Date:  2010-12       Impact factor: 4.098

7.  Is there an advantage over SF-36 with a quality of life measure that is specific to systemic lupus erythematosus?

Authors:  Zahi Touma; Dafna D Gladman; Dominique Ibañez; Murray B Urowitz
Journal:  J Rheumatol       Date:  2011-07-01       Impact factor: 4.666

Review 8.  A review of health related quality of life in systemic lupus erythematosus.

Authors:  K McElhone; J Abbott; L S Teh
Journal:  Lupus       Date:  2006       Impact factor: 2.911

9.  Exploring the validity of estimating EQ-5D and SF-6D utility values from the health assessment questionnaire in patients with inflammatory arthritis.

Authors:  Mark J Harrison; Mark Lunt; Suzanne M M Verstappen; Kath D Watson; Nick J Bansback; Deborah P M Symmons
Journal:  Health Qual Life Outcomes       Date:  2010-02-11       Impact factor: 3.186

10.  Using the health assessment questionnaire to estimate preference-based single indices in patients with rheumatoid arthritis.

Authors:  Nick Bansback; Carlo Marra; Aki Tsuchiya; Aslam Anis; Daphne Guh; Tony Hammond; John Brazier
Journal:  Arthritis Rheum       Date:  2007-08-15
View more
  4 in total

Review 1.  Incorporating the patient's perspective in outcomes research.

Authors:  Betty Hsiao; Liana Fraenkel
Journal:  Curr Opin Rheumatol       Date:  2017-03       Impact factor: 5.006

2.  Cost-Effectiveness of Acthar Gel Versus Standard of Care for the Treatment of Exacerbations in Moderate-to-Severe Systemic Lupus Erythematosus.

Authors:  Jas Bindra; Ishveen Chopra; Kyle Hayes; John Niewoehner; Mary Panaccio; George J Wan
Journal:  Adv Ther       Date:  2022-10-20       Impact factor: 4.070

Review 3.  Lupus community panel proposals for optimising clinical trials: 2018.

Authors:  Joan T Merrill; Susan Manzi; Cynthia Aranow; Anca Askanase; Ian Bruce; Eliza Chakravarty; Ben Chong; Karen Costenbader; Maria Dall'Era; Ellen Ginzler; Leslie Hanrahan; Ken Kalunian; Joseph Merola; Sandra Raymond; Brad Rovin; Amit Saxena; Victoria P Werth
Journal:  Lupus Sci Med       Date:  2018-03-23

4.  Sensitivity to Change and Minimal Important Differences of the LupusQoL in Patients With Systemic Lupus Erythematosus.

Authors:  Kathleen McElhone; Janice Abbott; Chris Sutton; Montana Mullen; Peter Lanyon; Anisur Rahman; Chee-Seng Yee; Mohammed Akil; Ian N Bruce; Yasmeen Ahmad; Caroline Gordon; Lee-Suan Teh
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-09-02       Impact factor: 4.794

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.